康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02162 康诺亚-B

未开盘 10-16 16:08:16

81.950

+5.800

+7.62%

最高86.250	最低78.000	成交量437.06万
今开78.000	昨收76.150	日振幅10.83%
总市值245.03亿	流通市值245.03亿	总股本2.99亿
成交额3.64亿	换手率1.46%	流通股本2.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02162","market":"HK","secType":"STK","nameCN":"康诺亚-B","latestPrice":81.95,"timestamp":1792138096005,"preClose":76.15,"halted":0,"volume":4370612,"delay":0,"changeRate":0.07616546290216673,"floatShares":299000000,"shares":299000000,"eps":-1.91,"marketStatus":"未开盘","change":5.8,"latestTime":"10-16 16:08:16","open":78,"high":86.25,"low":78,"amount":364202846,"amplitude":0.108339,"askPrice":82,"askSize":1500,"bidPrice":81.9,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":3.044545,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":0,"adr":0,"listingDate":1625673600000,"exchange":"SEHK","adjPreClose":76.15,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":2.127678259742856,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02162","defaultTab":"news","newsList":[{"id":"2675568581","title":"港股午评|恒生指数早盘涨1.21%     恒生创新药指数大涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675568581","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675568581?lang=zh_cn&edition=full","pubTime":"2026-10-16 12:01","pubTimestamp":1792123291,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数涨1.21%，涨290点，报24353点；恒生科技指数涨2.09%。港股早盘成交928亿港元。ESMO大会召开在即，恒生创新药指数大涨4.46%。成分股中，映恩生物-B涨超16%；康诺亚-B涨超8%；云顶新耀涨超8%；天辰生物-B涨超36%。内房股早盘回暖，深杭出台销售制度改革细则，其他城市出台速度有望加快。莎莎国际涨4%，富瑞指二季度销售表现好于预期，销售势头未见放缓。赣锋锂业跌超4%，前三季度纯利增长195倍，第三季纯利环比下滑68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1508144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1303224171.USD","LU0672654166.SGD","LU1048484197.HKD","BKF","LU0117841782.USD","89988","LU0630378692.HKD","03037","09988","LU0293314216.USD","LU0130518102.USD","LU0823397285.USD","LU2257852520.SGD","SGXZ86797644.SGD","BK1249","SG9999002828.SGD","LU1769817179.HKD","SG9999001689.USD","LU0918141705.HKD","LU0164872284.USD","LU0329678337.USD","LU0823040885.USD","BK1618","LU0650527681.SGD","LU0132412106.USD","LU0287142896.SGD","LU0049853897.USD","HK0000500386.USD","LU1201861165.SGD","LU3063872942.SGD","LU0608807433.USD","LU0117844026.USD","LU1961090484.USD","IE00BMPRXN33.USD","LU1048588211.SGD","LU0359202008.SGD","LU0871576103.HKD","LU0261950983.USD","LU0577902538.SGD","BK1608","LU0039217434.USD","LU0244354667.USD","LU1720051108.HKD","LU2125910849.SGD","LU0823426308.USD","BK1161","03115","LU2476274720.SGD","LU1366334651.USD","LU0029874905.USD","LU1105468828.SGD","LU0264606111.USD","LU1196710864.SGD","LU1515016050.SGD","03417","LU0169518387.USD","LU0320764599.SGD","LU1769817096.USD","02800","LU0456827905.SGD","LU0455707207.USD","LU2087589342.USD","LU0593848301.USD","MCHmain","LU0348814723.USD","BK1574","LU0165289439.USD","LU0543330566.HKD","LU2045819591.USD","LU0648000940.SGD","LU0348816934.USD","LU1868838027.USD","BK1142","LU0823041008.USD","BK1502","LU0259732245.USD","LU0327786744.USD","LU1366334578.USD","IE00B0JY6N72.USD","LU1794554557.SGD","HK0000107257.USD","LU1868837565.USD","LU0417516738.SGD","LU0051755006.USD","BK1615","LDEM","LU0634319403.HKD","LU0708995583.HKD","LU0577902298.EUR","LU0307460666.USD","KWEB","LU1282651121.HKD","LU0011963245.USD","LU1504937902.USD","LU0359201612.USD","IE00BZ08YR35.GBP","LU0463099449.HKD","LU0149534421.HKD","LU0140636845.USD","IE0032431581.USD","LU0048388663.USD","LU0106259558.USD","LU0441854154.USD","LU0642271901.SGD","BK1610","SG9999002463.SGD","LU0588545904.SGD","LU1956131251.USD","LU0823038988.USD","LU2293587155.HKD","IE00B0169N27.USD","LU1880398471.USD","LU1439103000.SGD","LU0499858438.USD","HSTECH","SGXZ62798434.SGD","SG9999001093.SGD","LU2226246903.HKD","LU0531971595.HKD","LU0054237671.USD","LU0561508036.HKD","LU0594300419.USD","07200","LU0762540952.USD","LU1808992512.USD","LU0791590937.USD","BK1583","03033","LU1048596156.SGD","LU0164865239.USD","LU0762542818.HKD","BK1588","LU0630378429.USD","LU0868486357.SGD","LU0784639295.USD","LU0737861699.HKD","LU0828237940.HKD","LU1720051017.SGD","LU0315179316.USD","LU1282649141.HKD","LU0543330483.HKD","IE00BZ08YT58.USD","BK1584","LU0608807946.USD","LU0328353924.USD","513600","ALBmain","LU0359201885.HKD","LU0396098781.USD","LU0469268626.HKD","LU0384037296.USD","LU0675040207.SGD","LU2097828714.EUR","LU0821914370.USD","LU0572940350.SGD","LU1880383440.USD","02162","LU1481107354.HKD","HK0000306685.HKD","LU0607220059.USD","LU0862451753.SGD","LU1770034418.SGD","LU0326950275.SGD","LU0029875118.USD","LU0502904849.HKD","LU0589944569.HKD","LU0449509016.USD","LU1224444064.USD","09606","LU2039709279.SGD","LU0149721374.USD","LU1188198961.HKD","LU2242644610.SGD","LU0588546209.SGD","07552","IE00B3M56506.USD","IE0034224299.USD","LU0648948544.HKD","SG9999000459.SGD","HSI","LU1023057109.AUD","LU2476274308.USD","LU0229945570.USD","LU1051768304.USD","SG9999000327.SGD","LU0531970944.HKD","LU0477156797.USD","SG9999004220.SGD","LU1051769294.HKD","LU2543165471.USD","09115","02837","LU0823413660.USD","LU0163747925.USD","LU0348735423.USD","LU1044874839.SGD","LU0831093199.SGD","LU0898667661.SGD","IE00B5MMRT66.SGD","BK1501","LU0823413587.USD","LU1831875114.USD","BK1591","LU0640798160.USD","LU0345776255.USD","LU2097828631.EUR","BABA","LU0329678170.USD","BK1586","LU0345775950.USD","SG9999001903.USD","LU0320764243.SGD","LU0797268264.HKD","LU1688375341.USD","HK0000306701.USD","LU0541501648.USD","LU1770036033.HKD","LU0047713382.USD","LU1328615791.USD","LU1242518931.SGD","LU0197773160.USD","LU1316542783.SGD","LU0873338254.USD","LU0979878070.USD","LU0865486749.SGD","LU0886674414.USD","LU2152927971.USD","IE00BZ08YS42.EUR","LU1568876335.HKD","01952","LU0210527791.USD","LU0072462343.USD","LU1880398554.USD","LU0261947096.USD","LU2125910500.SGD","LU1044875133.USD","LU0417516571.SGD","LU0214875030.USD","LU0052750758.USD","HHImain","FDNI","LU1282651048.USD","LU0228659784.USD","LU0540923850.HKD","03423","LU0370786039.SGD","LU0211977185.USD","LU0516423174.USD","LU0061477393.USD","LU0417516902.SGD","LU2399975544.HKD","LU0862451837.USD","LU0572939691.SGD","LU1242518857.USD","IE0003895053.USD","LU1807302812.USD","CXSE","LU0831103253.SGD","LU0228367735.SGD","82800","LU0084288322.USD","LU0106252389.USD","LU1655091459.SGD","83115","LU1044876610.USD","LU0588545730.USD","LU0320764755.SGD","LU0762541174.USD","BK1587","LU0128522157.USD","LU2488822045.USD","03419","LU0651947912.USD","LU0348805143.USD","LU0541502299.USD","LU0708995153.HKD","LU0577902371.SGD","LU1642822792.SGD","LU1719994722.HKD","LU1993786604.SGD","LU1282649810.SGD","HK0000151867.HKD","LU1548497426.USD","LU2097828805.USD","LU1115378108.SGD","LU0737861772.HKD","LU1323998911.USD","LU1981816686.USD","LU1810669033.SGD","LU0819123356.HKD","LU2097828557.USD","LU0577902611.USD","LU1720050803.USD","LU0516422952.EUR","LU0588545490.SGD","07226","IE0008368304.USD","LU2357305700.SGD","LU0594300179.USD","LU0173614495.USD","LU0048580855.USD","HK0000286598.CNH","LU0348783233.USD","LU0197773673.USD","LU0828237510.HKD","SG9999001226.SGD","LU0235996351.USD","03032","BK1521","LU0823426480.USD","LU0700851271.USD","LU1960683339.HKD","SG9999001051.SGD","LU0856984785.SGD","LU0130103400.USD","LU0431992006.USD","LU0918141887.USD","LU0572944931.SGD","LU2097828474.EUR","HK0000252152.HKD","LU0348784397.USD","SG9999006514.SGD","LU0516422366.SGD","09067","LU0127658192.USD","LU0251144936.SGD","LU0516422440.USD","LU1328277881.USD","LU0348825331.USD","HK0000320223.HKD","SG9999002562.SGD","LU1813983027.USD","07500","LU2778985437.USD","LU1224709979.USD","LU1211504680.USD","LU0210526637.USD","LU0254981946.USD","SGXZ90724238.SGD","LU0106959298.USD","LU0823039010.USD","LU0348783662.USD","LU0449515922.USD","LU1282649067.USD","LU0611395673.USD","SG9999014674.SGD","LU1206782309.USD","LU2449936058.SGD","LU0143863198.USD","LU0315178854.USD","LU0605514214.HKD","LU0143863784.USD","03088","LU0054450605.USD","LU0196878994.USD","IE00BPRC5H50.USD","LU0048597586.USD","HK0000320264.USD","LU1282648689.USD","SG9999006597.SGD","HBBD.SI","LU0823397103.USD","LU0577902454.USD","LU0516423091.SGD","LU0488056044.USD","LU0043850808.USD","09088","LU0164880469.USD","02833","LU0791591158.USD","LU0128522744.USD","LU0456846285.SGD","LU0499858602.USD","03067","IE00B543WZ88.USD","LU0348788117.USD","LU0890818403.SGD","IE00BMPRXR70.SGD","07300","LU1251922891.USD","LU0231483743.USD","LU0314109678.HKD","LU0096374516.USD","LU2294711473.HKD","LU1568876251.USD","LU0348827113.USD","LU0819121731.USD","LU0651946864.USD","LU1880383366.USD","HK0000165453.HKD","BK1575","HK0000252160.HKD","LU0181495838.USD","LU2097829019.USD","BK1517"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109072607","title":"创新药概念股续升，康诺亚涨超12%，云顶新耀涨超11%，金斯瑞生物涨近8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109072607","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109072607?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:51","pubTimestamp":1792115499,"startTime":"0","endTime":"0","summary":"港股创新药概念股续升，康诺亚涨超12%，云顶新耀涨超11%，金斯瑞生物涨近8%，百济神州涨超6%，再鼎医药涨近5%，药明合联、药明生物涨超4%，药明康德涨近4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","01548","06160","02269","02268","02162","02359","09688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107739839","title":"异动解读｜康诺亚-B盘中上涨11.1%，康悦达前三季度收入约6.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107739839","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107739839?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:50","pubTimestamp":1792115432,"startTime":"0","endTime":"0","summary":"10月16日，康诺亚-B盘中上涨11.1%，报84.6港元，成交额1.0亿港元。消息面上，公司披露核心产品康悦达前三季度收入总计约6.6亿元，同比增长约227%，主要受真实市场需求扩大及准入医院数量快速提升带动。同时，康悦达已于7月被纳入国家基本药物目录，并自9月起施行；公司亦披露青少年中重度特应性皮炎新适应症获批，且安全性数据未发现新的信号，进一步强化产品放量预期。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康诺亚盘中上涨，康悦达收入激增227%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675554081","title":"港股异动 | 康诺亚-B(02162.HK)涨超12% 康悦达®前三季度收入同比增长227%及获批新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2675554081","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675554081?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:46","pubTimestamp":1792115199,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1587","BK1161","02162","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675542315","title":"生物医药板块走强 康诺亚-B（02162）涨9.00%、金斯瑞生物科技（01548）涨7.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675542315","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675542315?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:37","pubTimestamp":1792114658,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块走强，康诺亚-B 涨9.00%，金斯瑞生物科技涨7.53%，百济神州涨5.38%，科伦博泰生物涨5.25%，再鼎医药涨4.46%，君实生物涨3.71%，泰格医药涨3.65%，复宏汉霖涨2.99%。中信建投证券表示，2026 ESMO LBA中国研究入选创新高，恒瑞医药、康方生物、艾力斯等企业的管线迎来新进展。医药商业板块跑赢申万医药及大盘，药店关注三季度前瞻及集采进药店，流通关注回款及三季度前瞻。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993835","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01877","02696","399441","LU2488822045.USD","LU0828237510.HKD","HK0000306701.USD","02162","06990","BK4588","HK0000165453.HKD","BK1161","09688","LU0196878994.USD","BK1515","HK0000320264.USD","BK4585","BK1141","03347","BK1500","LU0228659784.USD","KURE","LU2328871848.SGD","XBI","BK1587","BK4581","LU1969619763.USD","01548","LU1251922891.USD","LU1719994722.HKD","LU0307460666.USD","LU1303224171.USD","BK1588","BK1583","HK0000320223.HKD","LU1770034418.SGD","06160","BK1576","161726","HK0000306685.HKD","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126469078","title":"康诺亚-B：前三季度康悅達收入约6.6亿元增227%  青少年特应性皮炎新适应症获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1126469078","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126469078?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:10","pubTimestamp":1792109445,"startTime":"0","endTime":"0","summary":"2026年10月16日，康诺亚生物医药科技有限公司发布内幕消息表示，其核心产品康悅達在2026年前三季度录得收入约人民币6.6亿元，同比增加约227%。公司称，收入增长主要受真实市场需求扩大及医院准入数量快速提升带动。自2026年1月1日起，康悅達已获批的成人中重度特应性皮炎、慢性鼻窦炎伴鼻息肉及季节性过敏性鼻炎三项适应症，连同西林瓶及预充式自动注射笔两种规格，均被纳入中国国家医保药品目录，医保支付标准为人民币1,039元/支。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675008556","title":"康诺亚-B(02162)：康悦达®前三季度收入总计取得约6.6亿元 同比增长约227%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675008556","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675008556?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:10","pubTimestamp":1792109427,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康诺亚-B 发布公告，本公司产品康悦达于2026年前三季度收入总计取得约人民币6.6亿元，同比增长约227%，核心驱动来自于真实的市场需求和准入医院数量的急剧提升。同时2026年7月，康悦达 被正式纳入《国家基本药物目录》，自2026年9月1日起施行。安全性方面，司普奇拜单抗组与安慰剂组的治疗期间不良事件 发生率相当，且多为轻中度。此外，与成人研究结果相比，青少年中重度AD人群的安全性良好，未发现新的安全性信号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1508064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"康诺亚-B(02162)：康悦达®前三季度收入总计取得约6.6亿元 同比增长约227%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","02162","BK1574","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674823877","title":"光大证券：维持康诺亚-B(02162)“买入”评级 商业化快速放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2674823877","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674823877?lang=zh_cn&edition=full","pubTime":"2026-10-12 10:52","pubTimestamp":1791773525,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，光大证券发布研报称，考虑到26H1康诺亚-B核心产品康悦达销售收入实现高速增长，且CM336海外授权交易带来可观的一次性收益，该行上调2026年归母净利润预测为9.10亿元;考虑到公司研发管线全面加速推进，商业化不断提速，该行上调2027年归母净利润预测为0.46亿元，新增2028归母净利润预测为4.61亿元。公司核心产品商业化进入高速放量期，海外BD持续验证研发平台价值，后续管线梯队厚积薄发，维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02162","601788"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674188261","title":"生物医药板块继续回调 恒生生物科技指数跌2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674188261","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674188261?lang=zh_cn&edition=full","pubTime":"2026-10-09 10:17","pubTimestamp":1791512279,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块继续回调，恒生生物科技指数跌2.31%，恒生医疗保健指数跌2.09%。个股方面，复宏汉霖（02696）跌4.84%，药明康德（02359）跌3.92%，药明合联（02268）跌3.47%，泰格医药（03347）跌3.35%，诺诚健华（09969）跌3.27%，药明生物（02269）跌3.33%，金斯瑞生物科技（01548）跌3.10%，康诺亚-B（02162）跌2.58%，百济神州（06160）跌2.44%。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0540923850.HKD","LU1688375341.USD","LU1880383366.USD","02162","01548","02696","XBI","BK1141","LU0417516738.SGD","LU1831875114.USD","LU0516422440.USD","02268","LU2488822045.USD","LU2125910500.SGD","02269","IE00B0JY6N72.USD","LU0417516902.SGD","LU2778985437.USD","LU0320764243.SGD","LU0348825331.USD","LU0181495838.USD","LU2045819591.USD","BK4588","LU0128522744.USD","HK0000320264.USD","LU0588546209.SGD","02359","LU0856984785.SGD","HK0000306685.HKD","BK1521","LU0327786744.USD","KURE","SG9999002463.SGD","BK1161","LU0463099449.HKD","LU2039709279.SGD","LU0561508036.HKD","BK1576","09969","LU1251922891.USD","SG9999014674.SGD","399441","161726","LU0359202008.SGD","03347","06160","BK4581","LU2242644610.SGD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673064659","title":"生物医药板块大幅回调 恒生生物科技指数跌3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673064659","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673064659?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:35","pubTimestamp":1791336927,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块大幅回调，截至发稿，恒生生物科技指数跌3.15%，恒生医疗保健指数跌2.73%，万得港股中国创新药指数跌2.39%。个股方面，金斯瑞生物科技（01548）跌14.81%，再鼎医药（09688）跌4.47%，药明合联（02268）跌3.68%，药明生物（02269）跌2.50%，百济神州（06160）跌1.18%，诺诚健华（09969）跌1.43%，康诺亚-B（02162）跌1.32%，康方生物（09926）跌1.45%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993174","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880383366.USD","SG9999002463.SGD","LU0456827905.SGD","LU0572944931.SGD","BK1141","02268","09688","LU0244354667.USD","LU0320764243.SGD","LU0856984785.SGD","LU0052750758.USD","LU0211977185.USD","LU1242518857.USD","BK1574","LU0348825331.USD","IE00B543WZ88.USD","LU1794554557.SGD","06160","LU3063872942.SGD","09969","LU0516423174.USD","LU0228659784.USD","LU1720050803.USD","LU0417516738.SGD","LU0456846285.SGD","LU0588546209.SGD","01548","XBI","LU0359202008.SGD","161726","BK1161","LU2488822045.USD","LU0348784397.USD","KURE","LU2039709279.SGD","IE00B0JY6N72.USD","BK1521","399441","LU1242518931.SGD","SG9999014674.SGD","LU0561508036.HKD","LU0348766576.USD","02269","BK4588","SG9999002562.SGD","LU0320764599.SGD","09926","LU0828237510.HKD","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673033818","title":"生物医药板块走高 恒生生物科技指数涨2.32% 金斯瑞生物科技（01548）涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673033818","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673033818?lang=zh_cn&edition=full","pubTime":"2026-10-06 10:01","pubTimestamp":1791252073,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块走高，恒生生物科技指数涨2.32%，恒生医疗保健指数涨2.19%，万得中国创新药指数涨2.15%。个股方面，再鼎医药涨6.97%，金斯瑞生物科技涨5.30%，君实生物涨3.07%，药明生物涨3.07%，康方生物涨2.92%，康诺亚-B涨2.33%，泰格医药涨1.90%，诺诚健华涨1.87%。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993104","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1794554557.SGD","BK1515","SG9999002463.SGD","HK0000320223.HKD","IE00B543WZ88.USD","SG9999002562.SGD","LU0051755006.USD","03347","399441","LU0327786744.USD","01548","BK4581","KURE","LU0052750758.USD","LU0456827905.SGD","01877","LU0561508036.HKD","LU0359202008.SGD","HK0000306701.USD","LU0516423174.USD","LU0348784397.USD","LU2778985437.USD","LU1720050803.USD","LU0516422952.EUR","LU2039709279.SGD","IE00BPRC5H50.USD","LU0181495838.USD","LU1242518857.USD","LU1880383366.USD","XBI","LU0708995583.HKD","LU0417516902.SGD","02269","02162","LU0320764599.SGD","LU0039217434.USD","LU0128522744.USD","LU0140636845.USD","09926","09969","BK1141","LU0634319403.HKD","LU2488822045.USD","09688","LU0307460666.USD","BK1574","LU0708995153.HKD","161726","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164858594","title":"康诺亚-B更新9月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1164858594","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164858594?lang=zh_cn&edition=full","pubTime":"2026-10-05 16:38","pubTimestamp":1791189518,"startTime":"0","endTime":"0","summary":"康诺亚生物医药科技有限公司于2026年10月5日发布2026年9月股份变动月报表，报告期截至2026年9月30日。当月未发生任何增减变动，结存维持在500,000,000股，注册股本保持50,000美元不变。根据公告内容，康诺亚-B确认符合香港联交所《上市规则》规定的公众持股量要求。本月报表由执行董事Bo CHEN博士签署。公司表示将继续遵守香港联交所《上市规则》及相关法律法规的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671451293","title":"康诺亚-B午后涨逾9% 公司在自免、肿瘤等多个创新药领域具备强竞争优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2671451293","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671451293?lang=zh_cn&edition=full","pubTime":"2026-09-29 13:44","pubTimestamp":1790660640,"startTime":"0","endTime":"0","summary":"模拟交易客户端康诺亚-B午后涨超8%，截至发稿，股价上涨8.95%，现报79.70港元，成交额2.37亿港元。本月初，康诺亚宣布已与跨国医药公司 Aeira 就司普奇拜单抗注射液在东南亚和中亚等 18 个国家和地区的上市注册和商业化达成许可协议。中邮证券指出，康诺亚作为国内创新药出海新锐，在自免、肿瘤等多个创新药领域具备强竞争优势。2023年2月，阿斯利康以6300万美元首付款、超过11亿美元的里程碑付款拿下它的全球权益。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-29/doc-initnmwi2954177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","BK1161","159992","02162","06978","BK1583","LNGR","MEDX","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671293354","title":"创新药概念股逆市走强 康方生物（09926）涨16.85%、康诺亚-B（02162）涨10.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671293354","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671293354?lang=zh_cn&edition=full","pubTime":"2026-09-29 13:20","pubTimestamp":1790659249,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念股逆市走强，康方生物 涨16.85%，康诺亚-B涨10.32%，乐普生物涨7.88%，荣昌生物涨5.41%，科伦博泰生物涨5.32%，博安生物涨4.74%，恒瑞医药涨4.02%，再鼎医药涨4.02%。根据Insight数据，除已经在美国获批上市的药物外，已达成出海合作的国产创新药中有27款处于临床后期。其中，依沃西单抗、匹米替尼已在美国申请上市，芦康沙妥珠单抗、伦康依隆妥单抗、SSGJ-707等重点品种处于临床III期。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992749","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU0359201612.USD","LU0348783233.USD","09688","LU1969619763.USD","06990","BK1583","LU0348825331.USD","LU2476274308.USD","09995","LU0561508036.HKD","06978","02157","LU2778985437.USD","LU0359201885.HKD","LU0634319403.HKD","LU0417516738.SGD","09926","KURE","02162","LU0196878994.USD","LU0417516571.SGD","LU2328871848.SGD","IBBQ","MEDX","LU0348766576.USD","LU0417516902.SGD","BK1191","LU0348784397.USD","LU1794554557.SGD","BK1161","LU1961090484.USD","159992","LU0359202008.SGD","BK1588","IE00B5MMRT66.SGD","LU2488822045.USD","LU2543165471.USD","IE00BPRC5H50.USD","LU0348827113.USD","LNGR","LU1023057109.AUD","BK1587","01276","LU1720050803.USD","LU0348767384.USD","LU2476274720.SGD","LU0348735423.USD","06955","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671267526","title":"港股异动 | 康诺亚-B(02162.HK)盘中涨超8% 公司在自免、肿瘤等多个创新药领域具备强竞争优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2671267526","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671267526?lang=zh_cn&edition=full","pubTime":"2026-09-29 11:06","pubTimestamp":1790651193,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06978","BK1583","BK1587","02162","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183161849","title":"异动解读｜康诺亚-B盘中上涨8.48%，创新药板块受依沃西OS数据及阿斯利康战略投资提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1183161849","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183161849?lang=zh_cn&edition=full","pubTime":"2026-09-29 10:27","pubTimestamp":1790648834,"startTime":"0","endTime":"0","summary":"9月29日，康诺亚-B盘中上涨8.48%，报79.35港元，成交额1.25亿港元。康方生物盘中涨超11%，板块情绪共振带动康诺亚-B等自免及肿瘤管线标的跟涨。机构指出，创新药板块正迎来临床数据兑现与海外BD授权落地的估值修复窗口。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康诺亚-B异动拉升，创新药双重利好引爆","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669451177","title":"生物医药板块全线走低 诺诚健华（09969）跌10.48% 机构指行业需求尚未明显回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2669451177","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669451177?lang=zh_cn&edition=full","pubTime":"2026-09-24 13:36","pubTimestamp":1790228201,"startTime":"0","endTime":"0","summary":"金吾财讯 |  港股生物医药板块午后全线走低，截至发稿，诺诚健华 跌10.48%，荣昌生物跌7.99%，复宏汉霖跌7.68%，康诺亚-B跌5.86%，再鼎医药跌5.32%，君实生物跌4.53%，金斯瑞生物科技跌4.21%，康方生物跌3.54%，科伦博泰生物跌3.11%，泰格医药跌2.35%，药明生物跌1.80%，百济神州跌1.56%，药明合联跌1.12%。消息面上，国盛证券发布研报称，医药行业需求尚未明显回暖，降本增效、费用精细化管理已成为利润端的重要支撑。下半年关注流感旺季带来的阶段性需求催化。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992441","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518857.USD","LU2328871848.SGD","SG9999002562.SGD","LU2039709279.SGD","SG9999014674.SGD","LU1770034418.SGD","LU2399975544.HKD","01548","LU1303224171.USD","LU0516423174.USD","BK1576","399441","LU0516422366.SGD","02696","LU0348783233.USD","02162","09995","LU1961090484.USD","SG9999002463.SGD","01877","HK0000306701.USD","BK1141","LU0348825331.USD","LU0856984785.SGD","LU1719994722.HKD","LU1880383366.USD","02269","BK1515","09969","03347","06990","161726","06160","09688","LU0140636845.USD","XBI","688428","LU0828237510.HKD","02268","KURE","LU0456846285.SGD","LU1242518931.SGD","BK1583","LU0348766576.USD","LU0561508036.HKD","09926","BK4581","LU0540923850.HKD","LU3063872942.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107414156","title":"康诺亚-B 2026年上半年营收6.17亿元，经调整净利润12.18亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107414156","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107414156?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:09","pubTimestamp":1790068191,"startTime":"0","endTime":"0","summary":"康诺亚-B在2026年上半年实现营收6.17亿元，同比上涨24%。期内经调整净利润为12.18亿元，上一年同期则为亏损0.79亿元。毛利从上年同期的4.65亿元增加至4.98亿元。报告期内，经营活动所用净现金流量为2.54亿元，较上年同期多支出0.73亿元。报告期内，“康悦达”在医院准入和城市覆盖方面取得较好进展，实现销售收入3.93亿元，同比增长132%，在公司整体收入增长中贡献明显。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康诺亚-B 2026年上半年营收6.17亿元，经调整净利润12.18亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669139135","title":"港股异动 | 创新药概念股全线爆发 据报美国拟放宽药企授权许可合作 创新药BD估值有望修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2669139135","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669139135?lang=zh_cn&edition=full","pubTime":"2026-09-21 13:43","pubTimestamp":1789969421,"startTime":"0","endTime":"0","summary":"意味着新规不会一刀切封禁全部生物医药跨境交易，肿瘤ADC、双抗等常规抗癌创新药，允许海外药企收购管线、开展授权BD合作。中信建投指出，2026年世界肺癌大会中，中国创新药在肺癌领域全面发力，多个项目从早期探索迈入III期临床与全球化阶段。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498535.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","IE00BPRC5H50.USD","BK1574","HK0000165453.HKD","LU0326950275.SGD","LU0149534421.HKD","LU2242644610.SGD","159992","09926","KCAI","BK4588","BK1589","LU2399975544.HKD","MEDX","IE00B543WZ88.USD","LU1969619763.USD","LU0634319403.HKD","LU0417516571.SGD","LU1831875114.USD","02162","LU2097828474.EUR","LU0244354667.USD","BK1161","LU0455707207.USD","LU1720050803.USD","KURE","01801","BK1587","LU0348766576.USD","LU2097828714.EUR","LU0348735423.USD","LU0348767384.USD","LU0502904849.HKD","LU2476274308.USD","IBBQ","LU0417516738.SGD","09969","LNGR","BK4585","LU1794554557.SGD","LU2488822045.USD","LU2476274720.SGD","LU0348784397.USD","IE00B5MMRT66.SGD","LU0561508036.HKD","BK1583","VXUS","LU2778985437.USD","LU1961090484.USD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2669134373","title":"创新药概念股早盘全线爆发 康诺亚-B及康方生物均涨逾9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669134373","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669134373?lang=zh_cn&edition=full","pubTime":"2026-09-21 11:31","pubTimestamp":1789961460,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端创新药概念股早盘全线爆发，截至发稿，康诺亚-B（02162）上涨9.09%，报78.60港元；康方生物（09926）上涨8.90%，报98.55港元；诺诚健华（09969）上涨5.91%，报15.58港元；信达生物（01801）上涨6.21%，报102.60港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-21/doc-inisqeue5914872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0417516902.SGD","MEDX","IE00BPRC5H50.USD","LU0417516738.SGD","LU0348827113.USD","LU0348766576.USD","LU1961090484.USD","LU0348767384.USD","BK1574","LU0561508036.HKD","LU0634319403.HKD","09926","LU2476274720.SGD","LU1720050803.USD","IE00B543WZ88.USD","LU2488822045.USD","159992","BK1583","02162","BK1587","LU0348784397.USD","LU2778985437.USD","LU2399975544.HKD","LU0348825331.USD","LU0540923850.HKD","LU0348735423.USD","LU0348783233.USD","KURE","IBBQ","06978","LU1794554557.SGD","BK1161","LU0417516571.SGD","IE00B5MMRT66.SGD","LU2476274308.USD","LNGR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0466},{"period":"1month","weight":0.1188},{"period":"3month","weight":0.0037},{"period":"6month","weight":0.0341},{"period":"1year","weight":0.237},{"period":"ytd","weight":0.5332}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康诺亚生物医药科技有限公司是一家生物科技公司，专注于自主发现及开发自体免疫及肿瘤治疗领域的创新生物疗法的公司。该公司还专注于医药产品的研究和开发。该公司的主要产品有CM310、CM326、CM313和CM383，可治疗各种成人、青少年及儿童I型免疫性疾病，例如中重度特应性皮炎、中重度哮喘、慢性鼻賨炎伴鼻息肉、过敏性鼻炎，亦可能可以治疗慢性阻塞性肺疾病。该公司还建立了涵盖生物药开发的关键功能的全面一体化平台。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.062159},{"month":2,"riseRate":0.6,"avgChangeRate":0.057033},{"month":3,"riseRate":0.4,"avgChangeRate":0.01927},{"month":4,"riseRate":1,"avgChangeRate":0.079263},{"month":5,"riseRate":0.2,"avgChangeRate":-0.114444},{"month":6,"riseRate":1,"avgChangeRate":0.128513},{"month":7,"riseRate":0.6,"avgChangeRate":0.112367},{"month":8,"riseRate":0.666667,"avgChangeRate":0.036143},{"month":9,"riseRate":0.833333,"avgChangeRate":0.050215},{"month":10,"riseRate":0.5,"avgChangeRate":0.003431},{"month":11,"riseRate":0.6,"avgChangeRate":0.04569},{"month":12,"riseRate":0.2,"avgChangeRate":-0.144855}],"exchange":"SEHK","name":"康诺亚-B","nameEN":"KEYMED BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康诺亚-B,02162,康诺亚-B股票,康诺亚-B股票老虎,康诺亚-B股票老虎国际,康诺亚-B行情,康诺亚-B股票行情,康诺亚-B股价,康诺亚-B股市,康诺亚-B股票价格,康诺亚-B股票交易,康诺亚-B股票购买,康诺亚-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}